Pub. Date : 2005 Sep
PMID : 16038735
7 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | In vitro activity of the flt3-inhibitor su5614 and standard cytotoxic agents in tumour cells from patients with wild type and mutated flt3 acute myeloid leukaemia. | SU 5614 | fms related receptor tyrosine kinase 3 | Homo sapiens |
| 2 | In vitro activity of the flt3-inhibitor su5614 and standard cytotoxic agents in tumour cells from patients with wild type and mutated flt3 acute myeloid leukaemia. | SU 5614 | fms related receptor tyrosine kinase 3 | Homo sapiens |
| 3 | Tumour cells with internal tandem duplication (ITD) in the FLT3 receptor gene were significantly more sensitive to the FLT3 inhibitor SU5614 than tumour cells with wild type FLT3. | SU 5614 | fms related receptor tyrosine kinase 3 | Homo sapiens |
| 4 | Tumour cells with internal tandem duplication (ITD) in the FLT3 receptor gene were significantly more sensitive to the FLT3 inhibitor SU5614 than tumour cells with wild type FLT3. | SU 5614 | fms related receptor tyrosine kinase 3 | Homo sapiens |
| 5 | Tumour cells with internal tandem duplication (ITD) in the FLT3 receptor gene were significantly more sensitive to the FLT3 inhibitor SU5614 than tumour cells with wild type FLT3. | SU 5614 | fms related receptor tyrosine kinase 3 | Homo sapiens |
| 6 | Our results suggest that the FLT3 inhibitor SU5614 may have a therapeutic potential, especially in combination with other cytotoxic agents, in patients with FLT3-ITD positive AML. | SU 5614 | fms related receptor tyrosine kinase 3 | Homo sapiens |
| 7 | Our results suggest that the FLT3 inhibitor SU5614 may have a therapeutic potential, especially in combination with other cytotoxic agents, in patients with FLT3-ITD positive AML. | SU 5614 | fms related receptor tyrosine kinase 3 | Homo sapiens |